£740k
+2%vs Nov 2024Active06838431Private limited companyManchester
BIOXYDYN LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Bioxydyn Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BIOXYDYN LIMITED is an active private limited company (company number 06838431) incorporated on 5 March 2009, registered in Manchester. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 November 2025, showing net assets of £740k and cash of £18k, with 7 employees on average. Net assets rose 2% on the prior period (£724k). Across the last 3 periods on record the net-asset trend is flat.
Peer position · net assets
By net assets it sits in the top quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
02
Ownership and control
No active person with significant control is registered.
- Upf Nominees 1 Limited
- owns 25–50% of shares
- holds 25–50% of voting rights
- The North West Fund For Digital And Creative Lp
- has significant influence or control
- Mti Partners Limited
- holds 25–50% of voting rights
- has significant influence or control
- Nwf (Biomedical) Limited Partnership
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 5 March 200917 yrs ago
- Next accounts due
- 30 August 2027in 311 days
- Confirmation statement due
- 19 March 2027in 147 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£18k
−18%vs Nov 2024Not reported
7
No changevs Nov 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £740k | £18k | £265k | — | — | — | 7 |
| 30 November 2024 | £724k | £22k | £212k | — | — | — | 7 |
| 30 November 2023 | £707k | £48k | £210k | — | — | — | 8 |
Cash per employee£2,564Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £740,011 at 30 November 2025
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 5 March 2009
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 311 days
- Confirmation statement duein 147 days
- Accounts period endNet assets £740k · small accounts
- Accounts period endNet assets £724k · small accounts
- Accounts period endNet assets £707k · small accounts
- Incorporated
08
Similar companies in Manchester
- ANTIBODY APPLICATIONS LIMITEDMacclesfield · inc. Mar 2009
- DCN CORPORATION LIMITEDAshton-Under-Lyne · inc. Apr 2009
- SPHERITECH LIMITEDRuncorn · inc. Apr 2009
- INSTIL BIO (UK) LIMITEDMacclesfield · inc. Sept 2008
- PREVENT BREAST CANCER TRADING COMPANY LIMITEDManchester · inc. Sept 2009
- APEX MOLECULAR LIMITEDAlderley Edge · inc. May 2008
All companies incorporated on 5 March 2009 · in Mar 2009.
09
Reminders for BIOXYDYN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.